Stockfacts
Use CasesDocsPricing
Log inSign up free
OverviewFinancialsTrendsTranscriptsOptionsShortsInstitutionsInsidersCorporate ActionsSEC Filings
Stockfacts

EOD US-equity data for investors and AI agents

Data is end-of-day, not real-time, and not investment advice

Use CasesDashboard

BEAM

Beam Therapeutics Inc.

CIK 0001745999 · Nasdaq

NasdaqHealth CareBiological Products, (No Diagnostic Substances)
$29.76
↑ 1.37 (4.83%)
as of Aug 21, 2026
End-of-day close, not real-time intraday
Live price (Google Finance) ↗
Overall read: NeutralOverall score · based on 4/4 lenses
FundamentalsOwnershipTechnicalsOptions

Bullish: Ownership, Options; Risks: Fundamentals

Key stats

Market Cap
$3.07B
P/E Ratio
-35.98
EPS
-0.81
Dividend Yield
Not covered
52W Position
62%
Beta
2.11

Valuation multiples

Fwd P/E
Not covered
PEG
Not covered
P/B
2.88
P/S
19.70
EV/Revenue
18.93
ROE
-8.0%
Valuation data covers 8,711/9,697 US-listed stocks (89.8%).

Price · 1Y

251 trading days

End-of-day close, not real-time intraday

52-Week RangePosition 62%
$15.60$38.26

Latest Financials

2025-12-31 FY
Revenue
$139.74M
Net Income
-$79.99M
Total Assets
$1.48B
Free Cash Flow
-$360.05M

Recent news